BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1947 related articles for article (PubMed ID: 17581203)

  • 21. Interferon gamma impairs the ability of monocyte-derived dendritic cells to present tumour-specific and allo-specific antigens and reduces their expression of CD1A, CD80 AND CD4.
    Rongcun Y; Maes H; Corsi M; Dellner F; Wen T; Kiessling R
    Cytokine; 1998 Oct; 10(10):747-55. PubMed ID: 9811527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of purified allogeneic CD4(+) T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-gamma, IL-4, and IL-10.
    Janelidze S; Enell K; Visse E; Darabi A; Salford LG; Siesjö P
    Immunol Lett; 2005 Nov; 101(2):193-201. PubMed ID: 16002150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-beta induces the development of type 2 dendritic cells.
    Huang YM; Hussien Y; Yarilin D; Xiao BG; Liu YJ; Link H
    Cytokine; 2001 Mar; 13(5):264-71. PubMed ID: 11243704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability.
    Dzopalic T; Dragicevic A; Vasilijic S; Vucevic D; Majstorovic I; Bozic B; Balint B; Colic M
    Int Immunopharmacol; 2010 Nov; 10(11):1428-33. PubMed ID: 20817120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The maturation-dependent production of interleukin-16 is impaired in monocyte-derived dendritic cells from atopic dermatitis patients but is restored by inflammatory cytokines TNF-alpha and IL-1beta.
    Reich K; Hugo S; Middel P; Blaschke V; Heine A; Neumann C
    Exp Dermatol; 2004 Dec; 13(12):740-7. PubMed ID: 15560757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells.
    Oda N; Minoguchi K; Tanaka A; Yokoe T; Minoguchi H; Matsuo H; Nakashima M; Tasaki T; Adachi M
    Clin Exp Allergy; 2002 Dec; 32(12):1782-6. PubMed ID: 12653172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Roles of interleukin-10 differentiated dendritic cell of allergic asthma patients in T-lymphocyte proliferation in vitro].
    Tang JF; Guan SH; Wang ZG
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2851-4. PubMed ID: 23290216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
    Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
    Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells.
    Xia CQ; Kao KJ
    Int Immunol; 2003 Aug; 15(8):1007-15. PubMed ID: 12882838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients.
    Zou GM; Martinson J; Hu WY; Tam Y; Klingemann HG
    Cancer Immunol Immunother; 2004 Aug; 53(8):681-9. PubMed ID: 15103504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological characteristics of dendritic cells derived from peripheral blood of patients with epithelial ovarian cancer.
    Lan CY; Liu JH; Xia JC; Zheng LM
    Ai Zheng; 2009 Feb; 28(2):132-7. PubMed ID: 19550123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking.
    Peiser M; Wanner R; Kolde G
    J Leukoc Biol; 2004 Sep; 76(3):616-22. PubMed ID: 15178702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
    Li CD; Zhang WY; Yuan CL; Han LY
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cadinol and calamenene induce dendritic cells from human monocytes and drive Th1 polarization.
    Takei M; Umeyama A; Arihara S
    Eur J Pharmacol; 2006 May; 537(1-3):190-9. PubMed ID: 16631732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs.
    Rubio MT; Means TK; Chakraverty R; Shaffer J; Fudaba Y; Chittenden M; Luster AD; Sykes M
    Int Immunol; 2005 Dec; 17(12):1561-72. PubMed ID: 16303787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells.
    Bellinghausen I; Brand U; Steinbrink K; Enk AH; Knop J; Saloga J
    J Allergy Clin Immunol; 2001 Aug; 108(2):242-9. PubMed ID: 11496241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use.
    Kuroki H; Morisaki T; Matsumoto K; Onishi H; Baba E; Tanaka M; Katano M
    Cancer Immunol Immunother; 2003 Sep; 52(9):561-8. PubMed ID: 14627128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 98.